‘Regulation of Probiotics in the USA: Dietary Supplements,’ by Ivan Wasserman, IPA Counsel Corner, September 2016.
‘FTC Gets Into the ‘Natural’ Game — But Does it Advance the Ball?’, by Ivan Wasserman, New Hope Network, April 2016.
‘Pure Powdered Caffeine: Stakeholders Take Measure of FDA’s Warning Label,’ contribution by Rend Al-Mondhiry, FDLI’s Food and Drug Policy Forum, February 2016.
‘Chapter 33: Dietary Supplements and Homeopathic Products,’ (Update) Fundamentals of Regulatory Affairs (9th Edition), by Ashish Talati and Abhishek Gurnani, Regulatory Affairs Professional Society, 2015. 395-418.
Teva v. Sandoz: The New Standard of Review in Claim Construction, by J. Peter Paredes, Lexology, January 31, 2015.
Promega v. Life Technologies: A Higher Enablement Standard for “Comprising” Not Within the Preamble of the Claim, by J. Peter Paredes, Lexology, January 16 2015.
‘Phase III Biosimilar Clinical Trial & Infringement Threat Does Not Create Justiciable Case or Controversy: Biosimilars Will Require the Patent Dance,’ by Peter Paredes, Lexology, December 15 2014.
‘FeSSIFFaSSIF Dissolution: If You Understand What is Written Above You Should Read This Article’ by J. Peter Paredes, Lexology, December 8, 2014.
A new California law (AB 2030) prohibits the sale of over-the-counter diet pills and dietary supplements marketed for weight loss or muscle building to consumers under 18. Each violation is punishable by a civil penalty MORE >
see all news >